Potential Candidates for Focal Therapy in Prostate Cancer in the Era of Magnetic Resonance Imaging–targeted Biopsy: A Large Multicenter Cohort Study

Jost von Hardenberg,Angelika Borkowetz,Fabian Siegel,Kira Kornienko,Niklas Westhoff, Tobias B. Jordan,Manuela Hoffmann,Martin Drerup,Verena Lieb, Kasra Taymoorian,Martin Schostak,Roman Ganzer,Thomas Höfner,Hannes Cash,Johannes Bruendl

European Urology Focus（2021）

引用 12|浏览7

暂无评分

摘要

This study shows that less than one out of seven men is an eligible candidate for focal ablation after combined magnetic resonance imaging–targeted and systematic biopsy. Eligibility for focal therapy was defined as unifocal prostate cancer of International Society of Urological Pathology grade group ≤2 and prostate-specific antigen <15ng/mL. The potential for hemiablation is slightly higher, with one out of six men being eligible for focal ablation. Modality-specific limitations are not incorporated.

查看译文

关键词

Biopsy,Consensus,Eligibility criteria,Focal therapy,Focal therapy modalities,Hemiablation,Multiparametric magnetic resonance imaging,Patient selection,Partial gland ablation,Prostate neoplasms

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要